Improving Survival in Stage III Melanoma Published 2017-11-08 Download video MP4 360p Recommendations 11:47 What is Stage III Melanoma? 03:40 Developments in the Management of Stage III Melanoma 07:34 Adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib 02:13 Improving Outcomes in Spinal Muscular Atrophy 07:22 It started at Stage 1 and now it's Stage 3 |CANCER STORY| Ashlynn's Melanoma Diagnosis 16:34 Vitamin D Reduces Autoimmune Diseases: New Research 03:06 Melanoma Monday: Survival rates improving due to treatment advances 03:58 16+ Years Cancer-Free Thanks to Immunotherapy: Sharon Belvin's Melanoma Story 05:19 Diagnosing Melanoma 09:51 Living with Stage 3a Melanoma - Heather Hogendoorn 01:35 Dissection or Observation in Melanoma 02:13 Neoadjuvant Pembrolizumab for Lung Cancer | NEJM 02:44 What are the stages of melanoma? 12:08 Animated Introduction to Cancer Biology (Full Documentary) 05:11 First-of-its-Kind Advanced Melanoma Treatment 02:31 How Skin Cancer Spreads-Mayo Clinic 02:22 Adjuvant Pembrolizumab and Survival in Renal-Cell Carcinoma | NEJM 06:52 What Does My Tumor Grade Mean for Breast Cancer? Expert Insights 04:37 TAFINLAR® (dabrafenib) + MEKINIST® (trametinib) Mechanism of Action for Advanced Melanoma 01:42 Jak powstaje czerniak? Similar videos 10:18 Adjuvant ipilimumab improves recurrence-free survival in high-risk stage III melanoma 01:18 Comment: Ipilimumab in high risk stage III melanoma 27:18 Adjuvant and Neoadjuvant Dilemmas 09:00 When Do I Need Therapy for My Stage II or Stage III Melanoma? 28:21 Options for Treating Stage III Melanoma 05:51 Alternative Adjuvant Approaches in Stage III Melanoma 05:28 Ipilimumab as adjuvant therapy improves OS in high risk melanoma 05:29 Benefits and risks of treatment with ipilimumab after complete resection of Stage III melanoma 02:05 Dr. Weber on Adjuvant Approaches in Stage III Melanoma 05:00 Adjuvant Therapy for Stage III Melanoma 02:24 PRADO: personalized response-driven therapy in resectable stage III melanoma 01:59 CheckMate 238: nivolumab versus ipilimumab in stage III melanoma 02:33 OpACIN-neo & PRADO 3-year results in stage III melanoma: personalized neoadjuvant IO benefits 01:54 Neoadjuvant immunotherapy improves outlook in high-risk melanoma More results